PropertyValue
?:abstract
  • We describe a case of a 21 years old woman affected by Citrullinemia type 1- Arginosuccinate Synthase deficiency (ASSD)-who underwent a SARS CoV2 infection during the first phase of pandemic burst in Italy. She had no symptoms of infection nor a metabolic crisis. After recovery from SARS CoV2, she experienced a worsening in their epilepsy despite therapy, with one/two crisis a week.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.ymgmr.2020.100698
?:journal
  • Mol_Genet_Metab_Rep
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/730dbafcb3ef9600947a90b9c93730c46d63c755.json; document_parses/pdf_json/8d313d2e1c512226610198a3b4dc7fc635d6dbf8.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7745051.xml.json
?:pmcid
?:pmid
?:pmid
  • 33354515.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • SARS CoV2 infection in a young subject affected by arginosuccinate synthase deficiency: A case report of epilepsy worsening
?:type
?:year
  • 2020-12-11

Metadata

Anon_0  
expand all